Published On : February 2018 Pages : 91 Category: Medical Devices Report Code : HC02575
Industry Outlook and Trend Analysis
The global Intravenous (IV) Solutions Market was worth USD billion in 2017 and is expected to reach approximately USD billion by 2023, while registering itself at a compound annual growth rate (CAGR) of % during the forecast period. The development of this market is credited to the quickly developing aged populace and commonness of lack of healthy sustenance in the elderly and paediatric population. A substantial cohort of the populace aged 60 years or more is present over the globe, which is inclined to creating cardiac, gastrointestinal, and cancers, wounds, and neurological diseases. Additionally, progression in surgical processes and medications has expanded the future. The various surgical systems require therapeutic consideration, along these lines bringing about longer hospitalization. IV nutrition comprises a necessary part of any treatment to satisfy dietary requirements and help in quicker recuperation in patients.
Type Outlook and Trend Analysis
Based on the type of nutrition, the market is divided into PPN and TPN. TPN held a major share in 2017 attributable to the developing applications in the aged and paediatric populace combined with its necessity in the administration of chronic diseases, for example, tumour and ulcerative colitis. Commonness of malnutrition is high in the emerging nations. Around 3 million infant deaths happen each year because of malnutrition. Likewise, 165 million infants who survive have a diminished improvement rate and weakened cognitive abilities.
Nutrient Outlook and Trend Analysis
Based on nutrients, the market is fragmented into single dose amino acid solution, carbohydrates, vitamins and minerals (salt and electrolyte), parenteral lipid emulsion. Single dose amino acid held an impressive share in 2017, nearly took after by parenteral lipid emulsions. Rising pervasiveness of protein deficiency diseases, kidney failure, and hepatic ailments is adding to the high usage of amino acid infusions. Besides, expanded endorsements of upgraded amino acids with less unfriendly impacts are additionally powering the market development.
Regional outlook and Trend Analysis
In 2017, North America represented the most extreme income share of over %, trailed by Europe. The United States is the most essential market and records for the greatest offer of the North America area. Around 740 units of typical saline are used each moment in this locale. Additionally, the industry giant, Baxter, gives more than a million units for each day. Despite the fact that the request is high, U.S. encounters a deficiency of saline solutions because of a set number of providers and regular review frequencies.
Competitive Insights
The market is exceedingly diverse because of the existence of numerous universal and territorial organizations. Global organizations have the funds and a talented workforce to make items quick and at reasonable costs. The leading players in the market are JW Life Science, Fresenius Kabi, PT. Bhakti Widatra, Hospira, Baxter International, BioScrip Inc, B. Braun Melsungen and Terumo Corporation.
The Intravenous (IV) Solutions Market is segmented as follows-
By Type:
By Nutrients:
By Region
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing incidence of cancer
3.2.1.2. Rising geriatric population base
3.2.2. Restraints
3.2.2.1. Increased use of enteral nutrition
3.2.3. Opportunities
4. Intravenous Solutions Market, By Type
4.1. Introduction
4.2. Global Intravenous Solutions Sales, Revenue and Market Share By Type (2017-2017)
4.2.1. Global Intravenous Solutions Sales and Sales Share By Type (2017-2017)
4.2.2. Global Intravenous Solutions Revenue and Revenue Share By Type (2017-2017)
4.3. Intravenous Solutions Market Assessment and Forecast, By Type, 2017-2023
4.4. Peripheral Parenteral Nutrition (PPN)
4.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
4.5. Total Parenteral Nutrition (TPN)
4.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5. Intravenous Solutions Market, By Nutrients
5.1. Introduction
5.2. Global Intravenous Solutions Sales, Revenue and Market Share By Nutrients (2017-2017)
5.2.1. Global Intravenous Solutions Sales and Sales Share By Nutrients (2017-2017)
5.2.2. Global Intravenous Solutions Revenue and Revenue Share By Nutrients (2017-2017)
5.3. The Intravenous Solutions Market Assessment and Forecast, By Nutrients, 2017-2023
5.4. Single dose amino acids
5.4.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.5. Carbohydrates
5.5.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.6. Parenteral lipid emulsion
5.6.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.7. Vitamins and minerals
5.7.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
5.8. Other Nutrients
5.8.1. Market Assessment and Forecast, By Region, 2017-2023($Million)
6. Intravenous Solutions Market, By Region
6.1. Introduction
6.2. Intravenous Solutions Market Assessment and Forecast, By Region, 2017-2023 ($Million)
6.3. Global Intravenous Solutions Sales, Revenue and Market Share by Regions
6.3.1. Global Intravenous Solutions Sales by Regions (2017-2017)
6.3.2. Global Intravenous Solutions Revenue by Regions (2017-2017)
6.4. North America
6.4.1. North America Intravenous Solutions Sales and Growth Rate (2017-2017)
6.4.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.4.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.4. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.4.5. U.S.
6.4.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.5.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.4.6. Canada
6.4.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.6.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.4.7. Mexico
6.4.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.4.7.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5. Europe
6.5.1. Europe Intravenous Solutions Sales and Growth Rate (2017-2017)
6.5.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.5.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.4. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.5. Germany
6.5.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.5.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.6. France
6.5.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.6.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.7. UK
6.5.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.7.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.8. Italy
6.5.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.8.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.9. Spain
6.5.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.9.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.5.10. Rest of Europe
6.5.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.5.10.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Intravenous Solutions Sales and Growth Rate (2017-2017)
6.6.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.6.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.4. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.5. Japan
6.6.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.5.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.6. China
6.6.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.6.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.7. Australia
6.6.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.7.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.8. India
6.6.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.8.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.9. South Korea
6.6.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.9.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.6.10. Rest of Asia-Pacific
6.6.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.6.10.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7. Rest of the World
6.7.1. Rest of the World Intravenous Solutions Sales and Growth Rate (2017-2017)
6.7.2. Market Assessment and Forecast, By Country, 2017-2023($Million)
6.7.3. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.4. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.5. Brazil
6.7.5.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.5.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.6. Turkey
6.7.6.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.6.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.7. Saudi Arabia
6.7.7.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.7.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.8. South Africa
6.7.8.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.8.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.9. United Arab Emirates
6.7.9.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.9.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
6.7.10. Others
6.7.10.1. Market Assessment and Forecast, By Type, 2017-2023($Million)
6.7.10.2. Market Assessment and Forecast, By Nutrients, 2017-2023($Million)
7. Company Profiles
7.1. Grifols
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Intravenous Solutions Sales, Revenue and Market Share
7.2. Baxter
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Intravenous Solutions Sales, Revenue and Market Share
7.3. Hospira
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Intravenous Solutions Sales, Revenue and Market Share
7.4. Fresenius Kabi
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Intravenous Solutions Sales, Revenue and Market Share
7.5. Otsuka Pharmaceutical Co., Ltd.
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Intravenous Solutions Sales, Revenue and Market Share
7.6. Sino-Swed Pharmaceutical Corp., Ltd.
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Intravenous Solutions Sales, Revenue and Market Share
7.7. Amanta Healthcare
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Intravenous Solutions Sales, Revenue and Market Share
7.8. Terumo Corporation
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Intravenous Solutions Sales, Revenue and Market Share
7.9. Claris Lifesciences Ltd.
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.9.4. Intravenous Solutions Sales, Revenue and Market Share
7.10. Liqvor Pharmaceuticals
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Strategic Developments
7.10.4. Intravenous Solutions Sales, Revenue and Market Share
8. Global Intravenous Solutions Market Competition, by Manufacturer
8.1. Global Intravenous Solutions Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Intravenous Solutions Revenue and Market Share by Manufacturer (2017-2017)
8.3. Top 5 Intravenous Solutions Manufacturer Market Share
8.4. Market Competition Trend
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Intravenous Solutions Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|